Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients

Clinical trial NCT00417911 · COMPLETED

Trial details

NCT number: NCT00417911
Sponsor: Nordic Myeloma Study Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2005-12-01
Primary completion: 2009-05-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.